This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: The Innovative Contributions of Sarah Nicoletti
Introduction
Sarah Nicoletti is a prominent inventor based in Yeong-Gu, Incheon, South Korea. She has made significant strides in the field of biotechnology, particularly in the development of methods to enhance protein production in cell cultures. Her work is crucial for advancing recombinant protein production, which has applications in various medical and industrial fields.
Latest Patents
Sarah Nicoletti holds a patent titled "Methods of improving protein titer in cell culture." This patent focuses on improving recombinant protein titer and cell titer in cell culture by utilizing cell culture media with reduced impurities. The innovative media includes a HEPES buffer, which minimizes HEPES-related impurities. The methods and media she developed aim to enhance protein titer, cell growth, and viable cell density, making her contributions vital for the biotechnology industry.
Career Highlights
Sarah is currently employed at Regeneron Pharmaceuticals, Inc., where she continues to apply her expertise in biotechnology. Her work at Regeneron has allowed her to collaborate with other talented professionals in the field, furthering the impact of her innovations.
Collaborations
Some of her notable coworkers include Reginald Smith and Victor Shashilov. Their collaboration has likely contributed to the success of various projects within the company, enhancing the overall research and development efforts.
Conclusion
In summary, Sarah Nicoletti is an influential inventor whose work in improving protein titer in cell culture has significant implications for biotechnology. Her innovative methods and dedication to her field continue to drive advancements in recombinant protein production.